Inclusion criteria:
All patients meeting the following eligibility criteria will be included in the study:
  -  Patients enrolled into the IPP at one of the selected hospitals (see Annex 1 for IPP enrolment letter).
  -  Patients who received ≥1 dose of palbociclib as part of the IPP at one of the selected sites.
  -  For sites where data collection is performed by pH Associates, written informed consent will be required from living patients to access their medical records.
  -  Patient aged ≥18 years old at enrollment into the IPP